OTA International (Sep 2018)

Open reduction and internal fixation (ORIF) versus ORIF and primary subtalar arthrodesis for complex displaced intraarticular calcaneus fractures

  • Emmanuel David Eisenstein, MD,
  • Nicholas A. Kusnezov, MD,
  • Brian R. Waterman, MD,
  • Justin D. Orr, MD,
  • James A. Blair, MD

DOI
https://doi.org/10.1097/OI9.0000000000000005
Journal volume & issue
Vol. 1, no. 2
p. e005

Abstract

Read online

Abstract. Objectives:. To determine the optimal patient-oriented treatment between open reduction and internal fixation (ORIF) with or without primary subtalar arthrodesis (PSTA) for patients with displaced intraarticular calcaneus fractures (DIACFs, OTA 82-C3 and C4). Design:. Expected value decision analysis. Setting:. Academic military treatment facility Participants:. One hundred randomly selected volunteers. Intervention:. Hypothetical clinical scenario involving ORIF versus ORIF with PSTA. Main outcome measurements:. Decision analysis was used to elucidate the superior treatment option based on expected patient values, composed of: the product of the average outcome probabilities established by previously published studies and the average ascribed patient utility values for each outcome probability. One-way sensitivity analysis was performed to quantify the amount of change required for the inferior treatment to equal or surpass the superior option. Results:. Expected values for ORIF and ORIF with PSTA were 8.96 and 18.06, respectively, favoring ORIF with PSTA. One-way sensitivity analysis was performed by artificially decreasing the rate of secondary fusion following isolated ORIF thus increasing its overall expected value. Adjusting the rate of secondary fusion to 0%, the expected value of ORIF with PSTA nearly doubled that of ORIF (18.06 vs 9.45). Similarly, when adjusting the moderate and severe complication rates following ORIF with PSTA to 100%, the expected value of ORIF with PSTA still exceeded that of ORIF (15.45 vs 8.96, and 13.52 vs 8.96, respectively). Conclusion:. Expected value decision analysis favors ORIF with PSTA as the optimal treatment for complex DIACF.